trending Market Intelligence /marketintelligence/en/news-insights/trending/IOoQAbP7qQlLmCEgFoO6fg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Verastem appoints chief medical officer

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Verastem appoints chief medical officer

Verastem Inc. appointed NgocDiep Le as chief medical officer.

Le joins Verastem from AstraZeneca PLC unit MedImmune Inc. where she served as vice president, immuno-oncology innovative medicines.

She previously served as global clinical program head and executive medical director at Novartis AG's oncology unit.